Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease

Metabolism: Clinical and Experimental

Volumn 63, Issue 2, 2014, Pages 161-167

  Polyzos, Stergios A ^a   Mantzoros, Christos S ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ELASTOGRAPHY; FATTY LIVER; GOLD STANDARD; HISTOLOGY; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAGNETIC RESONANCE ELASTOGRAPHY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; REVIEW; ULTRASOUND;

ANIMALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892677099     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.10.010     Document Type: Editorial

References (66)

1. A.J. Sanyal NASH: a global health problem Hepatol Res 41 7 2011 670 674
2. S.A. Polyzos, J. Kountouras, and C. Zavos et al. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease J Clin Gastroenterol 46 4 2012 272 284
3. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 3 2011 274 285
4. J.A. Welsh, S. Karpen, and M.B. Vos Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010 J Pediatr 162 3 2013 496 500
5. V.G. Agopian, F.M. Kaldas, and J.C. Hong et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic Ann Surg 256 4 2012 624 633
6. G. Musso, R. Gambino, and M. Cassader et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 8 2011 617 649
7. Z.M. Younossi, M. Otgonsuren, and C. Venkatesan et al. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not Metabolism 62 3 2013 352 360
8. S.A. Polyzos, J. Kountouras, and C. Zavos Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines Curr Mol Med 72 3 2009 299 314
9. D. Schuppan, and J.M. Schattenberg Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches J Gastroenterol Hepatol 28 Suppl 1 2013 68 76
10. J. Ertle, A. Dechene, and J.P. Sowa et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis Int J Cancer 128 10 2011 2436 2443
11. M. Jacobs, M.M. van Greevenbroek, and C.J. van der Kallen et al. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study) Metabolism 60 7 2011 969 975
12. J.C. Sirota, K. McFann, and G. Targher et al. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey Metabolism 62 3 2013 392 399
13. A. Baranova, T.P. Tran, and A. Birerdinc et al. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 7 2011 801 814
14. E. D'Adamo, M.L. Marcovecchio, and C. Giannini et al. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children Metabolism 59 5 2010 671 676
15. G. Tarantino, and C. Finelli What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol 19 22 2013 3375 3384
16. V.L. Malloy, C.E. Perrone, and D.A. Mattocks et al. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice Metabolism 62 11 2013 1651 1661
17. H.J. Song, Y.G. Cho, and H.J. Lee Dietary sodium intake and prevalence of overweight in adults Metabolism 62 5 2013 703 708
18. H. Tsuchiya, Y. Ebata, and T. Sakabe et al. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice Metabolism 62 1 2013 62 69
19. C.W. Kim, Y. Chang, and E. Sung et al. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men Metabolism 61 8 2012 1182 1188
20. S.A. Polyzos, K.A. Toulis, and D.G. Goulis et al. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis Metabolism 60 3 2011 313 326
21. M. Yamaguchi, and T. Murata Involvement of regucalcin in lipid metabolism and diabetes Metabolism 62 8 2013 1045 1051
22. H.C. Hong, J.S. Lee, and H.Y. Choi et al. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey Metabolism 62 9 2013 1305 1312
23. S.A. Polyzos, J. Kountouras, and A. Papatheodorou et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease Metabolism 62 1 2013 121 126
24. N. Chalasani, Z. Younossi, and J.E. Lavine et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 6 2012 2005 2023
25. J.G. Fan, J.D. Jia, and Y.M. Li et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166) J Dig Dis 12 1 2011 38 44
26. V. Ratziu, S. Bellentani, and H. Cortez-Pinto et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2 2010 372 384
27. I. Sporea, A. Popescu, and R. Sirli Why, who and how should perform liver biopsy in chronic liver diseases World J Gastroenterol 14 21 2008 3396 3402
28. V. Ratziu, F. Charlotte, and A. Heurtier et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 7 2005 1898 1906 (Pubitemid 40824701)
29. D. Festi, R. Schiumerini, and L. Marzi et al. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods Aliment Pharmacol Ther 37 4 2013 392 400
30. M.V. Machado, and H. Cortez-Pinto Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal J Hepatol 58 5 2013 1007 1019
31. G. Weijers, A. Starke, and J.M. Thijssen et al. Transcutaneous vs. intraoperative quantitative ultrasound for staging bovine hepatic steatosis Ultrasound Med Biol 38 8 2012 1404 1413
32. C.T. Barry, B. Mills, and Z. Hah et al. Shear wave dispersion measures liver steatosis Ultrasound Med Biol 38 2 2012 175 182
33. A. Starke, A. Haudum, and G. Weijers et al. Noninvasive detection of hepatic lipidosis in dairy cows with calibrated ultrasonographic image analysis J Dairy Sci 93 7 2010 2952 2965
34. H.Y. Ou, P.H. Chao, and P.C. Yu et al. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T (1)H-magnetic resonance spectroscopy Transplant Proc 44 4 2012 955 958
35. J.R. van Werven, H.A. Marsman, and A.J. Nederveen et al. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model Magn Reson Imaging 30 1 2012 112 121
36. H.A. Marsman, J.R. van Werven, and A.J. Nederveen et al. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy J Magn Reson Imaging 32 1 2010 148 154
37. L.S. Szczepaniak, E.E. Babcock, and F. Schick et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo Am J Physiol 276 1999 E977 E989
38. S. Weisdorf, K. Hendrich, and H. Liu et al. An in vivo 31P magnetic resonance spectroscopy study of uridine excess in rats fed orotic acid Biochem Mol Med 54 1 1995 43 52
39. E. Hijona, J. Sanchez-Gonzalez, and J.M. Alustiza et al. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease Eur J Radiol 81 6 2012 1122 1127
40. C.D. Hines, H. Yu, and A. Shimakawa et al. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice Radiology 254 1 2010 119 128
41. X. Zhang, M. Tengowski, and L. Fasulo et al. Measurement of fat/water ratios in rat liver using 3D three-point dixon MRI Magn Reson Med 51 4 2004 697 702 (Pubitemid 38420445)
42. Y.F. Cheng, C.L. Chen, and C.Y. Lai et al. Assessment of donor fatty livers for liver transplantation Transplantation 71 9 2001 1221 1225 (Pubitemid 32507138)
43. T.R. DeGrado, S. Wang, and D.C. Rockey Preliminary evaluation of 15-[18 F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation J Nucl Med 41 10 2000 1727 1736
44. N. Salameh, B. Larrat, and J. Abarca-Quinones et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography Radiology 253 1 2009 90 97
45. S. Strauss, E. Gavish, and P. Gottlieb et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver AJR Am J Roentgenol 189 6 2007 320 323
46. C.K. Ryan, L.A. Johnson, and B.I. Germin et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation Liver Transpl 8 12 2002 1114 1122 (Pubitemid 35469871)
47. M. Fishbein, F. Castro, and S. Cheruku et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound J Clin Gastroenterol 39 7 2005 619 625 (Pubitemid 41061269)
48. C.C. Mottin, M. Moretto, and A.V. Padoin et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients Obes Surg 14 5 2004 635 637 (Pubitemid 38716583)
49. M.F. Xia, H.M. Yan, and W.Y. He et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method Obesity (Silver Spring) 20 2 2012 444 452
50. S.H. Park, P.N. Kim, and K.W. Kim et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment Radiology 239 1 2006 105 112
51. N.F. Schwenzer, F. Springer, and C. Schraml et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance J Hepatol 51 3 2009 433 445
52. A.E. Bohte, J.R. van Werven, and S. Bipat et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 21 1 2011 87 97
53. L.S. Szczepaniak, P. Nurenberg, and D. Leonard et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2 2005 E462 E468
54. F. Springer, J. Machann, and C.D. Claussen et al. Liver fat content determined by magnetic resonance imaging and spectroscopy World J Gastroenterol 16 13 2010 1560 1566
55. V.E. de Meijer, H.D. Le, and J.A. Meisel et al. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model Metabolism 59 8 2010 1092 1105
56. S. McPherson, J.R. Jonsson, and G.J. Cowin et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered J Hepatol 51 2 2009 389 397
57. J.A. Talwalkar, D.M. Kurtz, and S.J. Schoenleber et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis Clin Gastroenterol Hepatol 5 10 2007 1214 1220 (Pubitemid 47488974)
58. M. Friedrich-Rust, M.F. Ong, and S. Martens et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 4 2008 960 974
59. C. Fierbinteanu Braticevici, I. Sporea, and E. Panaitescu et al. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease Ultrasound Med Biol 39 11 2013 1942 1950
60. H. Ochi, M. Hirooka, and Y. Koizumi et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases Hepatology 56 4 2012 1271 1278
61. L. Huwart, C. Sempoux, and E. Vicaut et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis Gastroenterology 135 1 2008 32 40 (Pubitemid 351899024)
62. G. d' Assignies, G. Fontés, and C. Kauffmann et al. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels Metabolism 62 2013 1850 1857
63. L. Zhu, S.S. Baker, and W. Liu et al. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis Metabolism 60 7 2011 1001 1011
64. R. Banerjee, M. Pavlides, and E.M. Tunnicliffe et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease J Hepatol 2013 10.1016/j.jhep.2013.09.002
65. S.A. Polyzos, J. Kountouras, and A. Slavakis et al. A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study Biomarkers 2013 10.3109/1354750X.2013.838305
66. S. Polyzos, J. Kountouras, and A. Papatheodorou et al. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease - introduction of CHA index Ann Hepatol 12 5 2013 749 757